Remove news
article thumbnail

March 7, 2024: New Report Sets Out Posttrial Responsibilities in Pragmatic Clinical Trials

Rethinking Clinical Trials

Stephanie Morain In a new report from the NIH Pragmatic Trials Collaboratory, a team of bioethicists and implementation scientists argue for a “presumptive default” that the results of pragmatic clinical trials should be incorporated into healthcare delivery processes. Read the full article.

article thumbnail

December 13, 2023: In This Week’s PCT Grand Rounds, a Path Forward for Diversifying Clinical Trials

Rethinking Clinical Trials

In this Friday's PCT Grand Rounds, Roxana Mehran of the Icahn School of Medicine at Mount Sinai will present "Diversifying Clinical Trials: A Path Forward." Mehran is a professor of medicine and the director of interventional cardiovascular research and clinical trials at the Zena and Michael A. Join the online meeting.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MPE launches English Myeloma and AL Amyloidosis European Clinical Trial Navigator

Pharma Times

The tool will help people find out about clinical trials for myeloma, MGUS, SMM and AL amyloidosis

article thumbnail

Implementation and Intervention Complexity in Pragmatic Clinical Trials

Rethinking Clinical Trials

Implementation and Intervention Complexity in Pragmatic Clinical Trials Description Dr. Steven George of Duke University discusses implementation and intervention complexity in pragmatic trials, including highlights from a panel discussion at the NIH Pragmatic Trials Collaboratory's 2022 Steering Committee Meeting.

article thumbnail

Streamlining supply chain operations in focus at Clinical Trial Supply Europe 2024 

Pharmaceutical Technology

The upcoming Clinical Trial Supply Europe 2024 conference will round-up pharma and biotech delegates to discuss the trends and challenges in clinical trial supply industry.

article thumbnail

October 12, 2023: GRACE Team Shares Lessons About Monitoring Signals of Suicidality in Pragmatic Clinical Trials

Rethinking Clinical Trials

In a new article published this week in Contemporary Clinical Trials Communications, the GRACE Demonstration Project team recommends that suicidality should be monitored in pragmatic clinical trials that measure depression as an outcome. Learn more about the GRACE trial.

article thumbnail

Including Diverse Participants in Pragmatic Clinical Trials

Rethinking Clinical Trials

Biography Rosa Gonzalez-Guarda, PhD, MPH, RN, FAAN Associate Professor, Duke University School of Nursing Health Equity Core Co-chair Rachel Gold, PhD, MPH Kaiser Permanante Center for Health Research Karen Kehl, PhD, RN, FPCN National Institute of Nursing Research Related Read more in our news section.